Back to Search Start Over

A smart mobile health tool versus a paper action plan to support self-management of chronic obstructive pulmonary disease exacerbations: Randomized controlled trial

Authors :
Boer, L.M.
Bischoff, E.W.
Heijden, M van der
Lucas, P.J.F.
Akkermans, R.P.
Vercoulen, J.H.M.M.
Heijdra, Y.F.
Assendelft, W.J.J.
Schermer, T.R.J.
Boer, L.M.
Bischoff, E.W.
Heijden, M van der
Lucas, P.J.F.
Akkermans, R.P.
Vercoulen, J.H.M.M.
Heijdra, Y.F.
Assendelft, W.J.J.
Schermer, T.R.J.
Source :
JMIR mHealth and uHealth; 2291-5222; 10; vol. 7; e14408; ~JMIR mHealth and uHealth~~~~~2291-5222~10~7~~e14408
Publication Year :
2019

Abstract

Contains fulltext : 208886.pdf (publisher's version ) (Open Access)<br />Background: Many patients with chronic obstructive pulmonary disease (COPD) suffer from exacerbations, a worsening of their respiratory symptoms that warrants medical treatment. Exacerbations are often poorly recognized or managed by patients, leading to increased disease burden and health care costs. Objective: This study aimed to examine the effects of a smart mobile health (mHealth) tool that supports COPD patients in the self-management of exacerbations by providing predictions of early exacerbation onset and timely treatment advice without the interference of health care professionals. Methods: In a multicenter, 2-arm randomized controlled trial with 12-months follow-up, patients with COPD used the smart mHealth tool (intervention group) or a paper action plan (control group) when they experienced worsening of respiratory symptoms. For our primary outcome exacerbation-free time, expressed as weeks without exacerbation, we used an automated telephone questionnaire system to measure weekly respiratory symptoms and treatment actions. Secondary outcomes were health status, self-efficacy, self-management behavior, health care utilization, and usability. For our analyses, we used negative binomial regression, multilevel logistic regression, and generalized estimating equation regression models. Results: Of the 87 patients with COPD recruited from primary and secondary care centers, 43 were randomized to the intervention group. We found no statistically significant differences between the intervention group and the control group in exacerbation-free weeks (mean 30.6, SD 13.3 vs mean 28.0, SD 14.8 weeks, respectively; rate ratio 1.21; 95% CI 0.77-1.91) or in health status, self-efficacy, self-management behavior, and health care utilization. Patients using the mHealth tool valued it as a more supportive tool than patients using the paper action plan. Patients considered the usability of the mHealth tool as good. Conclusions: This study did not show beneficial effects o

Details

Database :
OAIster
Journal :
JMIR mHealth and uHealth; 2291-5222; 10; vol. 7; e14408; ~JMIR mHealth and uHealth~~~~~2291-5222~10~7~~e14408
Publication Type :
Electronic Resource
Accession number :
edsoai.on1284134554
Document Type :
Electronic Resource